Seres Therapeutics, Inc. (MCRB) › RevenueSeres Therapeutics, Inc. (MCRB) — RevenueAnnual figures by fiscal year, from SEC filings.2015: $02016: $21.77M2017: $32.10M2018: $28.27M2019: $34.51M2020: $33.22M2021: $144.93M2022: $7.13M2023: $02024: $02025: $789.0K$789.0K2015Revenue (USD)2025Fiscal YearRevenueChange YoY2025$789.0K—2024$0—2023$0-100.0%2022$7.13M-95.1%2021$144.93M+336.3%2020$33.22M-3.7%2019$34.51M+22.1%2018$28.27M-11.9%2017$32.10M+47.5%2016$21.77M—2015$0—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share